Literature DB >> 27914589

[Big data and their perspectives in radiation therapy].

Sébastien Guihard1, Juliette Thariat2, Jean-Baptiste Clavier3.   

Abstract

The concept of big data indicates a change of scale in the use of data and data aggregation into large databases through improved computer technology. One of the current challenges in the creation of big data in the context of radiation therapy is the transformation of routine care items into dark data, i.e. data not yet collected, and the fusion of databases collecting different types of information (dose-volume histograms and toxicity data for example). Processes and infrastructures devoted to big data collection should not impact negatively on the doctor-patient relationship, the general process of care or the quality of the data collected. The use of big data requires a collective effort of physicians, physicists, software manufacturers and health authorities to create, organize and exploit big data in radiotherapy and, beyond, oncology. Big data involve a new culture to build an appropriate infrastructure legally and ethically. Processes and issues are discussed in this article.
Copyright © 2016 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Big data; Cancer; Données patient; Métadonnées; Oncologie; Oncology; Ontologie; Ontology; Patient-reported outcome; Radiotherapy; Radiothérapie

Mesh:

Year:  2016        PMID: 27914589     DOI: 10.1016/j.bulcan.2016.10.018

Source DB:  PubMed          Journal:  Bull Cancer        ISSN: 0007-4551            Impact factor:   1.276


  2 in total

1.  Evaluating College Students' Comprehensive Quality by the AHP Algorithm.

Authors:  Tian Xia
Journal:  Comput Intell Neurosci       Date:  2022-05-16

2.  [New concepts of medical consultation in oncology].

Authors:  J-E Bibault; F Denis; S Guihard; J-B Clavier; C Durdux; P Giraud; S Kreps; S Maaradji; A Dautruche; E Fabiano; T Feutren; J Thariat
Journal:  Cancer Radiother       Date:  2020-08-01       Impact factor: 1.018

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.